Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

OncoGenex Pharmaceuticals Inc (NASDAQ:OGXI)

0.585
Delayed Data
As of Jan 17
 -0.015 / -2.50%
Today’s Change
0.33
Today|||52-Week Range
1.42
+17.02%
Year-to-Date
No recent news for OncoGenex Pharmaceuticals Inc.

Today’s Trading

Previous close0.60
Today’s open0.60
Day’s range0.59 - 0.60
Volume146,477
Average volume (3 months)628,636
Market cap$17.6M
Dividend yield--
Data as of 01/17/2017

Growth & Valuation

Earnings growth (last year)+55.86%
Earnings growth (this year)-32.81%
Earnings growth (next 5 years)--
Revenue growth (last year)-33.03%
P/E ratioNM
Price/Sales1.74
Price/Book0.47

Competitors

 Today’s
change
Today’s
% change
CBLICleveland Biolabs In...0.000.00%
ONTXOnconova Therapeutic...-0.04-1.58%
NEOTNeothetics Inc+0.03+2.62%
DPRXDipexium Pharmaceuti...-0.05-3.13%
Data as of 01/17/2017

Financials

Next reporting dateMarch 9, 2017
EPS forecast (this quarter)-$0.28
Annual revenue (last year)$18.2M
Annual profit (last year)-$16.8M
Net profit margin-92.52%

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO, Secretary, Treasurer &
Director
Scott Daniel Cormack
Chief Financial Officer &
Vice President
John A. Bencich
Corporate headquarters
Bothell, Washington

Forecasts


Search for Jobs